Skip to main content

The Women Who Helped Build Hollywood | The New Yorker

The Women Who Helped Build Hollywood | The New Yorker: Some scholars estimate that half of all film scenarios in the silent era were written by women, and contemporaries made the case, sometimes with old stereotypes, sometimes with fresh and canny arguments, that women were especially suited to motion-picture storytelling. In a 1925 essay, a screenwriter named Marion Fairfax argued that since women predominated in movie audiences—one reason that domestic melodramas, adventure serials featuring acts of female derring-do, and sexy sheikh movies all did well—female screenwriters enjoyed an advantage over their male counterparts. They were more imaginatively attuned to the vagaries of romantic and family life, yet they could write for and about men, too. After all, men “habitually confide in women when in need either of encouragement or comfort,” Fairfax wrote. “For countless ages woman’s very existence—certainly her safety and comfort—hinged upon her ability to please or influence men. Naturally, she has almost unconsciously made an intensive study of them.” Alice Blach�, the French-born director behind some six hundred short films, including “The Cabbage Fairy” (1896), one of the first movies to tell a fictional story, was one of many women to head a profitable production company. She founded hers, in 1910, with her husband and another business partner, in Flushing, New York, and moved it to Fort Lee, New Jersey, the pre-Hollywood filmmaking capital. Blach� wrote in 1914, “There is nothing connected with the staging of a motion picture that a woman cannot do as easily as a man, and there is no reason why she cannot completely master every technicality of the art.”

Popular posts from this blog

Elizabeth Holmes Discusses Theranos at WSJDLive 2015

Elizabeth Holmes Discusses Theranos at WSJDLive 2015 Elizabeth Holmes Discusses Theranos at WSJDLive 2015 At the WSJDLive 2015 conference, Theranos founder and CEO Elizabeth Holmes discusses her company's proprietary technologies, the FDA's inspection of its facilities, and the assertion that her company was too quick to market its products.